MDGL MADRIGAL PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2024 - Sales Agreement with TD Securities (USA) LLC Madrigal Pharmaceuticals, Inc. entered into a Sales Agreement with TD Securities (USA) LLC to issue and sell shares of common stock with an aggregate sales price of up to $300,000,000.Get access to all SEC 8-K filings of the MADRIGAL PHARMACEUTICALS INC